leadf
logo-loader
LSE:AVO GREY:AONCF FRA:R3I1

Advanced Oncotherapy PLC

Receive alerts
Market:
LSE
Market Cap:
£141.36 m
Price
40.50 GBX
Change
-1.22%
52 weeks high
50.00
52 weeks low
20.00

In brief

Advanced Oncotherapy is a specialist developer and provider of a breakthrough proton therapy system, the LIGHT system, which is the result of 25 years of work at CERN and ADAM.

Our focus is on developing and supplying technologies to maximise the destructive effect of radiation on tumours whilst minimising damage to the patient's healthy tissues.

Snapshot

  • Developing a smaller, more affordable proton beam therapy system called LIGHT
  • First patient set to be treated at Harley Street building next year
  • Technology-based on work by ADAM, a spin-off of CERN

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Proton beam therapy will become as common as MRI scanning believes Advanced Oncotherapy's chief executive

Nicholas Serandour explains the science and potential of Advanced Oncotherapy's pioneering proton therapy cancer treatment

on 9/8/19